快速凝血酶原试验的标准化；关于使用高效稳定凝血活酶时凝血酶原浓度变化的统计学意义。 - Suppr | 超能文献

Standardization of the Quick prothrombin test; with reference to the statistical significance of variations in the prothrombin concentration with use of a stable thromboplastin of high potency.

作者信息

AGGELER P M, HOWARD J

出版信息

Blood. 1946 May;1:220-33.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Standardization of the Quick prothrombin test; with reference to the statistical significance of variations in the prothrombin concentration with use of a stable thromboplastin of high potency.快速凝血酶原试验的标准化；关于使用高效稳定凝血活酶时凝血酶原浓度变化的统计学意义。

Blood. 1946 May;1:220-33.

2

[EVALUATION OF METHODS FOR THE DETERMINATION OF THE PROTHROMBIN COMPLEX ACTIVITY].[凝血酶原复合物活性测定方法的评估]

Z Arztl Fortbild (Jena). 1964 Jun 15;58:709-13.

3

[Blood coagulation in C avitaminosis. Part II. The change in the prothrombin and thrombotropin concentration and causes of decreased thromboplastin activity of the blood in C avitaminosis in guinea pigs].

Biull Eksp Biol Med. 1960 Mar;49:30-5.

4

BLOOD COAGULATION--A BASIC SCIENCE REVIEW.血液凝固——基础科学综述。

Conn Med. 1964 Sep;28:653-6.

5

Critical appraisal, clinical usefulness, and implementation of the thromboplastin concept of prothrombin-time standardization.凝血酶原时间标准化中凝血活酶概念的批判性评价、临床实用性及实施

Scand J Haematol Suppl. 1980;37:34-48. doi: 10.1111/j.1600-0609.1980.tb01340.x.

6

Complexes of protein-free lipid thromboplastin and prothrombin conversion factors; identifiable intermediates in the coagulation of blood.无蛋白脂质凝血活酶与凝血酶原转化因子的复合物；血液凝固中可识别的中间产物。

Am J Physiol. 1955 Aug;182(2):319-24. doi: 10.1152/ajplegacy.1955.182.2.319.

7

The one-stage prothrombin consumption test; clinical value in the identification of thromboplastin-deficiency diseases.一期凝血酶原消耗试验；在鉴别凝血活酶缺乏性疾病中的临床价值

Blood. 1950 Oct;5(10):964-72.

8

[The serum factor of prothrombin conversion acceleration. The specificity of thromboplastin].[凝血酶原转化加速的血清因子。凝血活酶的特异性]

J Physiol (Paris). 1950;42(4):865-75.

9

[Prothrombin time in the presence of a heterologous thromboplastin].[存在异源凝血活酶时的凝血酶原时间]

Rev Hematol. 1950;5(2):180-7.

10

Influence of concentration of thromboplastin on prothrombin time of human and dog plasma.凝血活酶浓度对人和犬血浆凝血酶原时间的影响。

Proc Soc Exp Biol Med. 1951 Apr;76(4):732-4. doi: 10.3181/00379727-76-18611.

引用本文的文献

1

Therapeutic target values in oral anticoagulation--justification of Dutch policy and a warning against the so-called moderate-intensity regimens.口服抗凝治疗的目标值——荷兰政策的依据及对所谓中等强度治疗方案的警示

Ann Hematol. 1992 Feb;64(2):60-5. doi: 10.1007/BF01715346.